Scientists in the UK have successfully treated a young girl with relapsed T-cell leukaemia using a revolutionary new type of gene therapy called base editing.
“This is our most sophisticated cell engineering so far, and it paves the way for other new treatments and ultimately better futures for sick children.”
– Wassem Qasim, Immunologist Professor and Project Leader
Alyssa, 13, had unsuccessfully undergone chemotherapy and a bone marrow transplant to treat her T-cell leukaemia, a cancer that affects white blood cells.
However, using a new method called base editing, scientists acquired T-cells from a healthy donor and changed its DNA, the new T-cells would then kill the old T-cells including the leukaemia cells.
Alyssa is now recovering after the successful procedure and has been in remission for six months.
The team at London’s Great Ormond Street hospital behind Alyssa’s treatment is now looking for another 10 T-cell leukaemia patients to verify the validity of the method.



